Dear Women's Imaging Insider,
Digital breast tomosynthesis (DBT) has everyone talking -- about whether it's effective, whether it boosts reader accuracy, and whether it cuts recall rates. But whether DBT lives up to the hype will have to await the installation of the first commercial DBT systems later this year.
DBT is the focus of this edition of the Women's Imaging Insider, as we bring you results from a pilot study on the technology from the University of Pittsburgh. Click here to find out what Dr. Walter Good and colleagues learned about ergonomic and performance issues as they relate to reading DBT exams. As a Women's Imaging Insider, you have access to the article well before the rest of our members.
As for other news you'll find in the Women's Imaging Digital Community, read about Hologic's plans to introduce DBT in Europe, and check out what researchers in Washington, DC, are saying about how best to evaluate cancer risk for patients with lobular neoplasia.
Finally, read how insurance payors are declining to reimburse for the use of breast MRI computer-aided detection (CAD) software, potentially putting the brakes on the growing use of breast MRI. The lack of reimbursement may also make it more difficult for breast centers to meet rising demand since the American Cancer Society issued guidelines in 2007 recommending an annual breast MRI exam for women with a high risk of breast cancer.
As always, if you have a comment, report, or article idea to share about any aspect of women's imaging, please feel free to contact me at [email protected].
